Is tobacco the unlikely Alzheimer's cure?
Star Scientific is developing CigRx, a nicotene-based compound that could help reduce brain inflamation and fight the disease
By Jeff Reeves, Editor, InvestorPlace.com
When you think about the tobacco industry, most folks probably don’t get a very good taste in their mouth. Investors think of massive lawsuits, steadily increasing taxes on cigarettes and dwindling smoker statistics choking off profits. And the general public thinks of lung cancer and that stale smell of Uncle Mickey’s jacket that infects the entire closet every time he visits for Thanksgiving.
But if tobacco stock Star Scientific (CIGX) has its way, the public could have a very different perception of tobacco in the future.
Namely, as the plant that cured Alzheimer’s.
So why haven’t you heard of this development? Well, because the results are preliminary and Star Scientific is burying its study on the potential cure in legalese and confusing press releases. As the pithy investor and journalist James Altucher wrote on Seeking Alpha, the latest press release from Star looked "looks like guys who got their law degree in some outpost of Antarctica wrote it."
Post continues after video:But here are the details: Star Scientific isolated a compound from nicotine, anatabine, that is a potential Alzheimer's treatment. After much hype, the neurological research mecca Roskamp Institute will finally begin human trials with the antabine compound (cleverly named CigRx, patented by Star Scientific and distributed by Inventiv). It will complete the study after three months.
To temper expectations, this is just the first step in a long process for any approval of an Alzheimer’s treatment. The study at Roskamp will focus on “inflammation,” and the theory appears to be that if chronic inflammation can be controlled or prevented then there is potential to fight the ravages of Alzheimer’s. Many medical experts suspect chronic inflammation is behind not just Alzheimer's but also cancer, heart disease and other serious ailments. Then even if the study is conclusive, there is a long process of refinement and further studies before any FDA approval that brings a cure or treatment to the general public.
But this is not just a pipe dream. A Roskamp article indicates that CigRx and antabine have already been linked to lower inflammation on human brain tissue – more so than the much lauded cholesterol maintentance drug Lipitor from Pfizer (PFE). Granted, Lipitor is not formulated for neurological health but for cardiac health, but the comparison indicates Star Scientific is moving in the right direction. If inflammation of the brain is, in fact, a big cause of Alzheimer’s symptoms and progression of the illness, then this could prove a crucial first step.
- Related Article: 7 Worst Health Care Stocks
Will the Alzheimer’s “cure” come to fruition? That’s still a big unknown. But in November the CEO of Star, Jonnie Williams, purchased a massive 717,220 shares of his own stock at a little under $2 a share. In the last six months, insiders have bought 4.13 million shares of Star Scientific.
That seems to indicate that the company has a lot of faith in its own leadership and product pipeline.
Jeff Reeves is editor of InvestorPlace.com. As of this writing, he did not own a position in any of the stocks named here. Follow him on Twitter via @JeffReevesIP and become a fan of InvestorPlace on Facebook.
Somebody out there thinks Americans are stupid! This was published years ago. The warning told us then that Nicotene was eventually going to be used to treat Alzheimer patients, obesity, and depression. The article went on the say that when drug companies want to market something, eventually, THEY get it. Yeah, it took a while, but they did get it. And so the truth about nicotene is, it's more beneficial ( and more profitable) as a Rx drug. Now to get rid of all those folks who get theirs for about $5.00 a pack and give them a bottle of pills for $50. Bottom line is, addiction is not the problem, profit margins are! How well propaganda works for the US.
Didn't the article read that the tobacco contains one component that may relate to the cure. Not the whole tobacco leaf.
just goes to show ya....they haven't got a clue what is good for ya and what might kill ya...looking like another thing to pump up the bottom line.
CigRx is a smoking alternative dietary supplement, and the reviews on both the site and the product facebook page speak for themselves.
Nowhere on either site is Alzheimer's even mentioned. Take a look at what the product is actually being used for, and how it is being marketed before throwing slings that "the company is claiming to have cured Alzheimer's with cigarettes." It is hard to argue against the product, and what it has been developed to actually do.
Since glutathione is the key antioxidant for the brain (vitamin E and E don't cross the blood brain barrier), I would think resolving glutathione deficiency would be a better cure and preventative! (Most people lose glutathione as we age - in part due to "natural aging", poor nutrition and our toxic environment.) I have seem direct improvement for Alzheimer's in both individuals and research via glutathione precursor supplementation.
Cigarettes are on of the causes of oxidative stress that causes inflammation. So is polution and our poor food supply.
Turns out that if we ate the proper foods, our body would be able to baturally mitigate the oxidative stress and resulting inflammation via the antioxidant that it manufactures itself from our food supply - glutathione.
Unfortunately we can''t just take glutathione as a supplement as it breaks down in our digestive system. We need to ingest the natural precursors to allow our body to build it naturally.
Low levels of glutathione are associated with almost every known illness. Conversely high levels are associated with a long and healthy life.
Raw milk is one source for these precursors, but they won't let us drink raw milk. In fact, there are many sources, but most are destroyed by processing, cooking and other "protective measures" due to m****duction. Our nutritionally depleted soils and junk foods add to the confusion.
The body knows how to mitigate illness! We just need to feed it properly!
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
An interest rate tease in The Wall Street Journal sends the market into an optimistic tizzy -- but one that doesn't end quite at the top.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.